AIMS/HYPOTHESIS: Mesenchymal stem cells (MSCs) have been shown to abrogate in vitro the proinflammatory response in type 1 diabetes. The mechanism involves paracrine factors, which may include microvesicles (MVs). We evaluated whether MVs derived from heterologous bone-marrow MSCs exert an immunomodulatory effect on T cell responses against GAD (glutamic acid decarboxylase) antigen in type 1 diabetes. METHODS: MVs were purified from heterologous human MSCs by differential centrifugation. Peripheral blood mononuclear cells (PBMCs) were obtained from patients with type 1 diabetes at disease onset, and responses to GAD65 stimulation were assessed by IFN-γ enzyme-linked immunosorbent spot analysis. Levels of cytokines and prostaglandin E2 (PGE2) were measured in the supernatant fraction, and T helper 17 (Th17) and regulatory T cell analysis was performed. RESULTS: MVs were internalised by PBMCs, as assessed by confocal microscopy and flow cytometry analyses. MVs significantly decreased IFN-γ spots and levels in GAD65-stimulated PBMCs, and significantly increased transforming growth factor-β (TGF-β), IL-10, IL-6 and PGE2 levels. Furthermore, MVs decreased the number of Th17 cells and the levels of IL-17, and increased FoxP3(+) regulatory T cells in GAD65-stimulated PBMCs. CONCLUSIONS/ INTERPRETATION: These results provide evidence that MSC-derived MVs can inhibit in vitro a proinflammatory response to an islet antigenic stimulus in type 1 diabetes. The action of MVs involves PGE2 and TGF-β signalling pathways and IL-10 secretion, suggesting a switch to an anti-inflammatory response of T cells.
AIMS/HYPOTHESIS: Mesenchymal stem cells (MSCs) have been shown to abrogate in vitro the proinflammatory response in type 1 diabetes. The mechanism involves paracrine factors, which may include microvesicles (MVs). We evaluated whether MVs derived from heterologous bone-marrow MSCs exert an immunomodulatory effect on T cell responses against GAD (glutamic acid decarboxylase) antigen in type 1 diabetes. METHODS: MVs were purified from heterologous human MSCs by differential centrifugation. Peripheral blood mononuclear cells (PBMCs) were obtained from patients with type 1 diabetes at disease onset, and responses to GAD65 stimulation were assessed by IFN-γ enzyme-linked immunosorbent spot analysis. Levels of cytokines and prostaglandin E2 (PGE2) were measured in the supernatant fraction, and T helper 17 (Th17) and regulatory T cell analysis was performed. RESULTS: MVs were internalised by PBMCs, as assessed by confocal microscopy and flow cytometry analyses. MVs significantly decreased IFN-γ spots and levels in GAD65-stimulated PBMCs, and significantly increased transforming growth factor-β (TGF-β), IL-10, IL-6 and PGE2 levels. Furthermore, MVs decreased the number of Th17 cells and the levels of IL-17, and increased FoxP3(+) regulatory T cells in GAD65-stimulated PBMCs. CONCLUSIONS/ INTERPRETATION: These results provide evidence that MSC-derived MVs can inhibit in vitro a proinflammatory response to an islet antigenic stimulus in type 1 diabetes. The action of MVs involves PGE2 and TGF-β signalling pathways and IL-10 secretion, suggesting a switch to an anti-inflammatory response of T cells.
Authors: Xunrong Luo; Hua Yang; Il Soo Kim; Fludd Saint-Hilaire; Dolca A Thomas; Bishnu P De; Engin Ozkaynak; Thangamani Muthukumar; Wayne W Hancock; Ronald G Crystal; Manikkam Suthanthiran Journal: Transplantation Date: 2005-05-15 Impact factor: 4.939
Authors: James L Reading; Jennie H M Yang; Shereen Sabbah; Ania Skowera; Robin R Knight; Jef Pinxteren; Bart Vaes; Timothy Allsopp; Anthony E Ting; Sarah Busch; Amy Raber; Robert Deans; Timothy I M Tree Journal: J Immunol Date: 2013-04-01 Impact factor: 5.422
Authors: Lindsay C Davies; Jessica J Alm; Nina Heldring; Guido Moll; Caroline Gavin; Ioannis Batsis; Hong Qian; Mikael Sigvardsson; Bo Nilsson; Lauri E Kyllonen; Kaija T Salmela; Per-Ola Carlsson; Olle Korsgren; Katarina Le Blanc Journal: Stem Cells Transl Med Date: 2016-07-13 Impact factor: 6.940
Authors: James R Klinger; Mandy Pereira; Michael Del Tatto; Alexander S Brodsky; Keith Q Wu; Mark S Dooner; Theodore Borgovan; Sicheng Wen; Laura R Goldberg; Jason M Aliotta; Corey E Ventetuolo; Peter J Quesenberry; Olin D Liang Journal: Am J Respir Cell Mol Biol Date: 2020-05 Impact factor: 6.914